000 | 01919 a2200541 4500 | ||
---|---|---|---|
005 | 20250515050424.0 | ||
264 | 0 | _c20070516 | |
008 | 200705s 0 0 eng d | ||
022 | _a0022-3573 | ||
024 | 7 |
_a10.1211/jpp.58.11.0013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSasaki, Sumiyo | |
245 | 0 | 0 |
_aProtective role of gamma-aminobutyric acid against chronic renal failure in rats. _h[electronic resource] |
260 |
_bThe Journal of pharmacy and pharmacology _cNov 2006 |
||
300 |
_a1515-25 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 |
_aAlbuminuria _xetiology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xadministration & dosage |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCatalase _xmetabolism |
650 | 0 | 4 |
_aCreatinine _xurine |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDrinking _xdrug effects |
650 | 0 | 4 |
_aEating _xdrug effects |
650 | 0 | 4 |
_aGlutathione Peroxidase _xmetabolism |
650 | 0 | 4 |
_aHypercholesterolemia _xetiology |
650 | 0 | 4 |
_aHypolipidemic Agents _xadministration & dosage |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 |
_aKidney Failure, Chronic _xetiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNephrectomy _xadverse effects |
650 | 0 | 4 |
_aOrgan Size _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aSodium _xurine |
650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
650 | 0 | 4 |
_aThiobarbituric Acid Reactive Substances _xmetabolism |
650 | 0 | 4 |
_aUrination _xdrug effects |
650 | 0 | 4 |
_agamma-Aminobutyric Acid _xadministration & dosage |
700 | 1 | _aYokozawa, Takako | |
700 | 1 | _aCho, Eun Ju | |
700 | 1 | _aOowada, Shigeru | |
700 | 1 | _aKim, Mujo | |
773 | 0 |
_tThe Journal of pharmacy and pharmacology _gvol. 58 _gno. 11 _gp. 1515-25 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1211/jpp.58.11.0013 _zAvailable from publisher's website |
999 |
_c16702840 _d16702840 |